Agenus
Agenus is a clinical‑stage biotech developing immuno‑oncology therapies and vaccine adjuvants, featuring the Retrocyte Display platform for human antibodies. Phase II assets like Balstilimab and AGEN1181, plus key partnerships, drive high‑growth oncology prospects.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Professional Services
- Industry: Biotechnology Research
- Employees: 316
- HQ: Lexington
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.